Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,17 USD | -1,12% | -8,18% | +9,20% |
Attività
Numero di dipendenti: 145
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Targeted Protein Degradation
100,0
%
| 31 | 100,0 % | 21 | 100,0 % | -33,25% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 31 | 100,0 % | 21 | 100,0 % | -33,25% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 14/09/20 |
Kendra Adams
DFI | Director of Finance/CFO | 48 | 20/11/20 |
Chief Tech/Sci/R&D Officer | - | 01/01/21 | |
Stewart Fisher
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/05/16 |
Leonard Reyno
CTO | Chief Tech/Sci/R&D Officer | 61 | 10/07/23 |
Courtney Solberg
IRC | Investor Relations Contact | - | - |
Mark Mossler
AUD | Comptroller/Controller/Auditor | 51 | 01/06/23 |
Scott Boyle
PRN | Corporate Officer/Principal | 46 | 01/01/22 |
Adrian Bignami
PRN | Corporate Officer/Principal | - | 01/04/21 |
Jolie Siegel
LAW | General Counsel | 47 | 01/06/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Bruce Downey
CHM | Chairman | 76 | 01/12/15 |
Glenn Dubin
BRD | Director/Board Member | 67 | 12/03/21 |
Bihua Chen
PRN | Corporate Officer/Principal | 55 | 01/12/15 |
Donna Grogan
BRD | Director/Board Member | 67 | 29/07/22 |
Owen Hughes
BRD | Director/Board Member | 49 | 20/11 |
Kenneth Anderson
FOU | Founder | 72 | 01/10/15 |
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 14/09/20 |
Malcolm Salter
BRD | Director/Board Member | 84 | 01/12/15 |
Utpal Koppikar
BRD | Director/Board Member | 53 | 16/03/22 |
Laura Bessen
BRD | Director/Board Member | 61 | 29/07/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 68 600 669 | 60 629 707 ( 88,38 %) | 0 | 88,38 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+9,20% | 423 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione CCCC
- Società C4 Therapeutics, Inc.